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ABSTRACT 
Background & Aims: Gastrostomies are widely used to provide long-term enteral 
nutrition to patients with neurological conditions that affect swallowing (such as 
following a cerebrovascular accident or for patients with motor neuron disease) or 
with oropharyngeal malignancies. The benefits derived from this intervention are 
uncertain for patients and caregivers. We conducted a prospective, multicenter cohort 
study to determine how gastrostomies affect health-related quality of life (HRQoL) in 
recipients and caregivers. 
Methods: We performed a study of 100 patients who received gastrostomies (55% 
percutaneous endoscopic gastrostomy, 45% radiologically inserted) at 5 centers in the 
United Kingdom, 100 caregivers, and 200 population controls. We used the EuroQol-
5D (EQ-5D, comprising a questionnaire, index, visual analogue scale) to assess 
HRQoL for patients and caregivers before the gastrostomy insertion and then 3 
months afterward; findings were compared with those from controls. Ten patients and 
10 caregivers were also interviewed after the procedure to explore quantitative 
findings. Findings from the EQ-5D and semi-structured interviews were integrated 
using a mixed methods matrix. 
Results: Six patients died before the 3-month HRQoL reassessments. We observed 
no significant longitudinal changes in mean EQ-5D index scores for patients (0.70 
before vs 0.710 after; P=.83) or caregivers (0.95 before vs 0.95 after; P=.32) 
following gastrostomy insertion. The semi-structured interviews revealed problems in 
managing gastrostomy tubes, social isolation, and psychological and emotional 
consequences that reduced HRQoL.  
Conclusions: We performed a mixed methods prospective study of the effects of 
gastrostomy feeding on HRQoL. HRQoL did not significantly improve after 
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gastrostomy insertion for patients or caregivers. The lack of significant decrease in 
HRQoL after the procedure indicates that gastrostomies may help maintain HRQoL. 
Findings have relevance to those involved in gastrostomy insertion decisions and 
indicate the importance of carefully selecting patients for this intervention, despite the 
relative ease of insertion. 
Keywords: Outcome, Decision making, PEG, RIG, Mixed Methods 
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INTRODUCTION  
Gastrostomies are widely used to provide long-term enteral nutrition when oral intake 
is inadequate. They are most frequently performed in patients with neurological 
conditions affecting swallowing (e.g., post cerebrovascular accident, motor neurone 
disease) and in those with oropharyngeal malignancy.1 17,000 gastrostomies are 
estimated to be inserted annually in the United Kingdom, compared to 125,000 
procedures in the United States of America.2-5 These estimate values and paucity of 
contemporary data internationally, highlight the uncertainty that currently exists in the 
medical literature regarding the frequency of enteral access placements.4  
 
Although these procedures are widely performed, controversies exist regarding the 
merits of this intervention. These controversies reflect the absence of an evidence 
base supporting their role in certain patient groups, and the high morbidity and 
mortality identified in others.6-9 Quality of life is another important health outcome 
measure, which has been poorly characterized in this group of patients. Improving an 
understanding of this outcome measure is pertinent to those involved in the decision-
making process regarding gastrostomy insertion, as improvements in survival and 
nutritional status could be perceived to be of limited gains, if no quality of life 
improvements are achieved for patients.  
 
Health-related quality of life (HRQoL) can be defined as the way illness, pain and 
motor activity influences daily behavior, social activities, psychological well-being 
DQGRWKHUDVSHFWVRIDQLQGLYLGXDO¶VOLIH10 Currently, an understanding of HRQoL in 
gastrostomy patients has been focused on patients with cancer 11-18, despite most 
gastrostomy insertions occurring in non-cancer individuals.19-21 The influence 
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gastrostomies have on caregivers is also poorly appreciated. A recent British Medical 
Journal editorial discusses the impact healthcare interventions have on caregivers and 
raises concerns about the current paucity of knowledge about caregiver outcomes.22 
Researchers are now challenged to provide better evidence of the effectiveness and 
efficiency of healthcare intervention from the perspective of all individuals involved 
in healthcare decisions (i.e. inclusive of caregivers). Through advancing 
understanding of caregiver outcomes, the novel concept of ³Farer-proofing´ 
healthcare decisions can be achieved.22 This need to carer/caregiver -proof healthcare 
decisions is pertinent to gastrostomy insertion decisions.  
 
Mixed methods research can be used to assesses HRQoL. Mixed methods research 
combines elements from differing research methods (e.g. quantitative and qualitative 
methodologies) to produce converging findings in the context of complex research 
questions.23 The use of this novel technique has increased over recent years through 
its ability to enhance understanding, and achieve clinically relevant findings.24 
Another merit of this technique is that views from individual patients and caregivers 
are expressed. Incorporation of LQGLYLGXDO¶V reported outcomes has the potential of 
helping inform the clinical decision making process, pertinent to gastrostomy 
insertion decisions.25 This prospective, multicenter study aimed to evaluate how 
gastrostomies influence HRQoL in both patients and caregivers using mixed methods 
research.  
 
 
 
 
 7 
METHODS 
Setting 
Adult participants (>16 years old) were enrolled from five hospitals in South 
Yorkshire and North East Derbyshire, United Kingdom (Royal Hallamshire Hospital, 
Northern General Hospital, Chesterfield Royal Hospital, Rotherham Hospital, 
Doncaster Royal Infirmary). These hospitals in combination serve a population of just 
over 1.5 million people and perform approximately 350 gastrostomies annually.26 At 
all hospitals percutaneous endoscopic gastrostomy (PEG) and radiologically-inserted 
gastrostomies (RIG) were available as potential methods of inserting a gastrostomy. 
No surgically inserted gastrostomies were performed during the study period. 
Selection as to which procedure was undertaken was left to the discretion of the 
referring clinician, with similar outcomes following the two techniques (PEG and 
RIG) reported previously by our group.27 
 
 
Group 1 ± Assessment of HRQoL 
An explanatory sequential mixed methods design was used incorporating two 
differing HRQoL assessment tools.28 The rationale for using a mixed methods 
approach ZDVWRDWWDLQDPRUHFRPSOHWHSLFWXUHRIDQLQGLYLGXDO¶VTXDOLW\RIOLIHXVLQJ
different forms of complementary data. The two-phase design of this study involved 
collection and analysis of quantitative data from patients and caregivers, prior to a 
second phase when qualitative data was collected. This approach enabled exploration 
and possible explanation of the quantitative findings and was used to assist in 
sampling.  
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Participants 
Patients referred for a gastrostomy and caregivers of patients with a gastrostomy were 
eligible for inclusion in this study. Participants were excluded if they were too unwell, 
unable to communicate or if English was not understood. Caregivers were defined as 
an adult family member or friend providing unpaid care for an individual with a 
gastrostomy. Patients were most frequently recruited alongside their own caregivers, 
although occasionally patients and caregivers were recruited in isolation if their 
counterpart was ineligible for the study (e.g. unable to communicate).  
 
Nutrition teams within individual hospitals helped identify potential participants for 
this study, who were then approached by clinical research nurses if they agreed. 
Information sheets were provided either by direct contact with the participant in 
hospital or by writing to them personally at home. In both cases, individuals were 
contacted a few days after the information sheet was provided, to question if they 
wanted to meet and discuss the study further with a member of the research team or 
take part. The research team met those who wanted to meet and following informed 
consent being obtained, participants were enrolled.  
 
 
Phase 1: Quantitative Assessment 
EuroQol-5D (EQ-5D) is the National IQVWLWXWH RI &OLQLFDO ([FHOOHQFH¶s (NICE) 
preferred measure of HRQoL in adults.29 It is a quick and easy bedside tool that takes 
2-3 minutes to complete consisting of a questionnaire, index and visual analogue scale 
(VAS).  EQ-5D has previously been evaluated in the area of gastrostomy feeding.10 
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Five dimensions (mobility, self-care, usual activity, pain/ discomfort and anxiety/ 
depression) and three levels (no problems, some problems, extreme problems) in the 
EQ-5D questionnaire create 243 unique health states. These states can be then 
converted into a single index value between -0.59 and 1.00, facilitating the calculation 
of quality-adjusted life years (QALYs). The VAS is a millimeter scale, 20 cm in 
length, ranging from 0 (worst imaginable HRQoL) to 100 (best imaginable HRQoL). 
7KH9$6FRPSOHPHQWVWKHVXEMHFW¶VGHVFULSWLRQRI+54R/within the questionnaire.  
 
In this study, we use EQ-5D to assess HRQoL in both patients and caregivers at 
baseline (prior to gastrostomy insertion) and then again at 3 months (post insertion). 
The decision to reassess patients and caregivers at 3 months was pragmatic, allowing 
sufficient time for gastrostomy feeding to have any potential influence on HRQoL, 
whilst also considering the high mortality rates identified previously following this 
intervention. In addition, to assessing longitudinal changes in HRQoL in both patients 
and caregivers using EQ-5D, findings at 3 months post gastrostomy insertion were 
compared with a control group drawn from the general population of Sheffield.  
 
Phase 2: Qualitative Assessment 
Semi-structured interviews were conducted on a sample of participants who had 
undergone phase 1. The principle investigator (MK) undertook these interviews, 
having had no previous involvement in the clinical decision-making process regarding 
gastrostomy insertion, which could have potentially influenced responses.  Purposive 
sampling was undertaking to ensure assessment of a cross sectional cohort with 
differing underlying conditions. Findings and variables assessed in Phase 1 study 
were used to refine interview schedules for the semi-structured interviews, aiming to 
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gain a richer understanding of results obtained using the quantitative assessment. 
Most questions asked were open ended and undertaken face-to-face within 
LQGLYLGXDO¶V RZQ KRPHV or if requested in private surroundings within hospitals. 
Slight differences were made to the interview schedule of the caregivers when 
compared to the patients, reflecting the impact gastrostomy insertion had on them 
personally. Most participants were interviewed in isolation, however two patients 
requested the presence of a relative during the interviews, which was allowed. In 
patients with dysarthria, written communication was permitted during the course of 
the interviews. All interviews were undertaken in English, with an average length of 
22 minutes. Following informed consent, interviews were tape recorded and 
transcribed later, with all potentially identifying information excluded or coded.  
Transcripts were sent to participants to be reviewed afterwards, ensuring accuracy of 
the transcription and allowing a means of quality control.  
 
 
Analysis 
The phase 1 quantitative data findings were analyzed using statistical packages for the 
social sciences (SPSS Inc., Chicago, Illinois, USA), version 20.0. Baseline and 3 
month post-insertion EQ-5D index and VAS scores were compared using a paired t-
test, after Shapiro-Wilk normality testing indicated a good fit (p value >0.05). An 
independent T-test was used to compare findings between differing groups, with p 
values <0.05 considered significant. In phase 2 of the study, a thematic interpretive 
analysis was used, where transcripts were coded in NVivo (QSR International Pty 
Ltd. Version 10) using a coding structure, based on the interview schedule and 
findings from Phase 1. These codes were subsequently organized by theme, enabling 
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comparisons to be made between differing individuals. Integration of the EQ-5D 
findings and semi-structured interviews was then done using a mixed methods matrix, 
allowing further exploration and understanding of quantitative findings from the 
qualitative data 30  
 
Ethical Considerations 
This study protocol was: approved by the Yorkshire and the Humber Research Ethics 
committee (REC reference - 11/YH/0152), registered with the Sheffield Research and 
Development department (reference - STH15871) and included in the National 
Institute for Health Research Clinical Research Network Portfolio (Portfolio ID -
11090).  
 
RESULTS 
A total of 100 gastrostomy patients and 100 caregivers were prospectively recruited 
during the study period, alongside 200 population controls. Characteristics of these 
individuals are demonstrated in Table 1. PEGs accounted for 55% of the gastrostomy 
insertions, with the remaining insertions being performed radiologically (RIGs). All 
caregivers completed follow up assessment at 3 months, however 6% (6/100) of the 
patients who underwent a gastrostomy died prior to their 3-month follow up. Of these 
6 individuals, 3 had PEG insertion and 3 had RIG insertions.  
 
Phase 1 ± Quantitative Data (EQ-5D) 
Table 2 shows baseline and 3-month follow up EQ-5D scores for both patients and 
caregivers, alongside EQ-5D scores for the population controls. When analysing 
longitudinal changes in HRQoL scores, no significant change in mean EQ-5D index 
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scores was noted in either the patients (0.70 versus. 0.71, p=0.83) or the caregivers 
(0.95 versus. 0.95, p=0.32) following gastrostomy. These findings were corroborated 
by the EQ-VAS, with mean scores unchanged at 3 months in either the patient group 
(67.2 versus 67.4, p=0.65) or in the caregivers (96.5 versus 96.7, p=0.18).  
 
When compared to population controls, caregivers had comparable HRQoL (mean 
EQ-5D index score = 0.95 versus 0.93, p=0.87) following gastrostomy unlike the 
patients, who had significantly lower HRQoL at 3 months (mean EQ-5D index score 
= 0.73 versus 0.94, p<0.0001). Outcomes in the gastrostomy patients did differ 
dependent on the underlying referral indication, with lowest HRQoL at 3 months 
being in individuals who had a previous cerebrovascular accident (mean EQ-5D index 
score = 0.513), followed by progressive neurodegenerative conditions (mean EQ-5D 
index score = 0.657) and then oropharyngeal malignancy (mean EQ-5D index score = 
0.835). In the 9 patients who underwent a gastrostomy for alternative indications the 
mean EQ-5D index score was 0.756. 
 
Phase 2 ± Semi-structured Interviews  
Ten patients and ten caregivers agreed to participate in the interviews. Of the patients, 
two had undergone a gastrostomy following a previous cerebrovascular accident, four 
had oropharyngeal cancer and four had progressive neurological conditions. Six of the 
caregivers were partners of patients requiring a gastrostomy; two were children of 
patients and two were siblings. Individually, they cared for six patients with 
progressive neurological disease, three with oropharyngeal cancer and one who had a 
previous cerebrovascular accident. The framing of the topics for the semi-structured 
interviews were informed by the findings from Phase 1 where lower HRQoL in 
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patients was identified, alongside differences according to referral indication. 
Questions devised encouraged discussions as to why HRQoL was lower in patients 
and exploring factors that may have influenced these outcomes. Five main themes 
were identified from the data analysis: expectations of gastrostomy feeding, 
gastrostomy management, physical wellbeing, psychological and emotional welfare, 
and social consequences of gastrostomy feeding. Each theme is discussed below 
incorporating both patients and caregivers insights. 
 
Expectations of gastrostomy feeding 
Both patients and caregivers at the commencement of gastrostomy feeding conveyed 
high expectations, with aspirations that it would help improve nutrition and help 
survival. Many felt that information about gastrostomy feeding was well 
communicated by healthcare professionals at the outset, but some wished to have had 
more information, particularly pertaining to some of the long term issues and 
practicalities. Most agreed that after three months, the gastrostomy had met 
expectations with regards to nutritional benefits (e.g. weight gain, halting previously 
identified weight loss), however two caregivers questioned this benefit as the SDWLHQW¶V
underlying medical condition had not significantly improved.  
 
Gastrostomy management 
Once at home, caregivers KDG DQ LQWHJUDO SDUW LQ WKH PDQDJHPHQW RI SDWLHQWV¶
gastrostomy tubes. Many expressed early anxiety and lack of education as barriers to 
initial success, which were overcome with further experience and support from 
differing healthcare professionals. Some caregivers expressed a dependence on 
themselves to provide the feeding regimes to their relatives, which influenced their 
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own daily routines. Although frequently expressed as being time consuming and 
sometimes messy, many patients and caregivers were accepting of the need for 
gastrostomy feeding, and had adopted strategies to maintain daily lifestyles and social 
interactions.  
 
Physical Wellbeing 
A number of patients noted improvement in fatigue levels following gastrostomy 
insertion, however this did not necessarily reflect improvements in actual physical 
function, with underlying diseases usually determining capabilities. Two patients 
commented on improvements in reflux and vomiting symptoms post gastrostomy. No 
direct influence of gastrostomy feeding was identified on the physical wellbeing of 
caregivers. 
 
Psychological and emotional welfare 
In both patients and caregivers, perceptions of psychological and emotional wellbeing 
were diverse. Patients frequently expressed long-term health as a concern and the 
impact this may have on their friends and family. One patient expressed a view that 
the gastrostomy feeding tube was a burden to them and their partner but that they had 
no alternative if they wanted to survive. The impact of not being able to eat was also 
explored in all patients and many missed the sensation of being able to eat and taste in 
the normal manner, when compared to feeding via a gastrostomy. With regards to the 
caregivers, concerns most often expressed by them were regarding their loved ones 
who had undergone gastrostomy placement and their future health. Financial concerns 
were also of anxiety to some, having previously been managed by their partners.  
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Social consequences of gastrostomy feeding 
Three patients reported that they felt socially excluded because they could not eat 
meals in a normal manner following gastrostomy This made it difficult for them to 
watch other people eat and enjoy food, so they actively avoided mealtimes and often 
going out. Others felt that exclusion of mealtimes was beneficial to them following 
gastrostomy, as the pressure and struggle to eat no longer existed. With regards to 
getting out of the house, some patients and caregivers expressed that the gastrostomy 
was more discrete than other nutritional support methods, enabling them to do their 
normal daily activities in public without the perception of others of being unwell.   
 
Integration of Phase 1 and 2   
Following identification of differing mean EQ-5D scores in the different gastrostomy 
referral subgroups a mixed methods matrix was created to explore findings (Table 3). 
This helped provide a number of potential explanations as to why gastrostomy 
patients have lower HRQoL when compared to the general population. Interestingly, 
whilst some of the responses from the interviews were disease specific, most 
perceptions provided by participants were relevant to all groups with social isolation, 
complications and management issues of tubes all being pertinent to gastrostomy 
patients¶ and caregivers¶ HRQoL. 
 
DISCUSSION 
This is the first mixed-methods study performed in gastrostomy feeding, 
demonstrating that HRQoL does not significantly improve in either patient recipients 
or caregivers following gastrostomy insertion. Although improvements were not 
identified, HRQoL did not significantly change over time in either group. Given that 
 16 
gastrostomy recipients frequently have chronic progressive illnesses where a 
deterioration in HRQoL may be expected, the demonstration that HRQoL may be 
preserved following gastrostomy insertion is important and could be used to inform 
gastrostomy insertion decisions.  
 
In the first part of this study, quantitative assessment demonstrated that gastrostomy 
patients had significantly lower HRQoL compared to population controls, which was 
further explored using semi-structured interviews. This mixed methods approach 
enabled a better understanding of HRQoL in these individuals, and also provided 
insights into the impact this had on their caregivers. Findings from this study could be 
used to support future clinical decisions regarding gastrostomy insertions and 
pRWHQWLDOO\³FDUHU-SURRI´WKHPE\better informing both patients and their caregivers 
about the merits of this intervention.31, 32 This research could also provide an 
opportunity to co-produce with patients a resource to aid shared decision-making.33, 34 
 
The importance of patient selection and the need to appropriately counsel patients and 
their caregivers before gastrostomy insertion is emphasized by this research. Although 
gastrostomies are relatively easy to perform, challenges are frequently encountered 
regarding gastrostomy insertion decisions in certain patients. Factors considered on an 
individual basis include survival, healing of pressure sores, reduction of aspiration 
and the possibility of discharge to a nursing home.35 Ethical and medico-legal issues 
add to the complexity of this decision making, alongside assessments of risk (both 
procedural and patient related).36 Our research attempts to better characterize HRQoL. 
Although this is only 1 facet involved in the complex decision making process, this 
outcome has advantages over other measures in being a patient and a caregiver 
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reported outcome. Given the importance of patient autonomy in decision making, we 
believe that the true merits of our work is in helping endoscopists and healthcare 
teams provide more accurate and factual, but sensitive, education regarding 
gastrostomy benefits to both patients and their family.35, 36 Given the absence of 
prospective randomized controlled trials evaluating the alternatives to gastrostomy 
feeding (e.g. long-term nasogastric feeding, optimizing oral feeding techniques or 
confining nutritional intake to DSDWLHQW¶VRZQYROLWLRQ this work could help better 
inform both patients and their caregivers.  
 
Although this study has strengths in being prospective in design, multicenter, and 
novel in using mixed methods, there are potential limitations to this work. Firstly, 
patients who were too unwell or could not participate due to cognitive or 
communicative problems were not included in the HRQoL assessment. This could 
have resulted in a selection bias. This may also explain why the mortality was 
relatively low in this group of patients at 6% at 3 months. In addition, in assessing 
longitudinal change in HRQoL a longer follow-up of individuals beyond 3 months 
could have demonstrated different outcomes and potential improvements in HRQoL. 
The high baseline HRQoL in caregivers (comparable to the general population) may 
have also limited the opportunity for an improvement in HRQoL over time. 
 
Another limitation of this work is in the analysis of EQ-5D findings. Both patients 
and caregiver groups showed no statistically significant change in mean index or VAS 
scores between baseline and 3 months. Whilst this may not represent statistical 
significance, slight differences in index scores could be deemed to be clinically 
relevant. Although there is a paucity of work evaluating the smallest change in EQ-
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5D index score needed to be important, one study found that the minimally important 
difference (MID) in EQ-5D index scores was 0.07 in 11 different patient groups (not 
including gastrostomy patients), which was not achieved in either our patient or 
caregiver groups at 3 months.37  
 
The validity of our comparator group to assess HRQoL is another potential limitation 
to our work. In this study we used population controls to compare HRQoL with both 
patients and caregivers. An alternative and possibly better comparator group could 
have been patients with similar diagnoses who refused or who were deferred a 
gastrostomy. Although this issue was considered, our previous study evaluating 
deferred gastrostomy patients showed that often these individuals were more unwell, 
limiting their potential to complete our HRQoL assessments, recruitment into the 
study and potentially raising questions as to their suitability as appropriate 
comparators.38 Although we recognize this limitation, we feel our study design was 
pragmatic and addresses a common perception that gastrostomies lead to 
improvement in outcomes.   
 
Previous published data assessing HRQoL following gastrostomy insertion is 
conflicting, with some studies suggesting HRQoL benefit following gastrostomy 
insertions.12, 39, 40 This study adds to the literature by being the largest prospective 
study evaluating a cross sectional cohort of gastrostomy patients, and provides 
longitudinal outcomes in both gastrostomy patients and their caregivers. What our 
findings do support from previous work is that HRQoL does vary in gastrostomy 
patients dependent upon the referral indication.10, 40 When our findings are considered 
in the context of our previous work evaluating mortality and other recently published 
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prospective mortality studies, it would appear that patients with oropharyngeal cancer 
have the best outcomes, both with regards to mortality and HRQoL .38, 41 Our study 
also provides insights into why patients with gastrostomy feeding tubes have lower 
HRQoL when compared to population controls. Whilst underlying conditions did 
influence HRQoL, the burden associated with managing gastrostomy feeding tubes, 
the feelings of social isolation and the impact this had psychological and emotional 
well-being were cross cutting themes pertinent to most gastrostomy patients and 
caregivers.  
 
In conclusion, HRQoL does not significantly improve in either patient recipients or 
caregivers following gastrostomy insertion, although the absence of a significant fall 
suggests gastrostomies may still confer benefits by maintaining HRQoL. This work 
emphasizes the importance of patient selection and the need to appropriately counsel 
patients and their caregivers before gastrostomy insertion.  
 
 
  
 20 
REFERENCES 
1. Kurien M, McAlindon ME, Westaby D, et al. Percutaneous endoscopic 
gastrostomy (PEG) feeding. BMJ 2010;340:c2414. 
2. Roche V. Percutaneous endoscopic gastrostomy. Clinical care of PEG tubes in 
older adults. Geriatrics 2003;58:22-6, 28-9. 
3. Duszak R, Jr., Mabry MR. National trends in gastrointestinal access 
procedures: an analysis of Medicare services provided by radiologists and 
other specialists. J Vasc Interv Radiol 2003;14:1031-6. 
4. Day LW, Nazareth M, Sewell JL, et al. Practice variation in PEG tube 
placement: trends and predictors among providers in the United States. 
Gastrointest Endosc 2015;82:37-45. 
5. NCEPOD. Scoping our practice: the 2004 report of the National Confidential 
Enquiry into Patient Outcome and Death.  2005. 
6. Sanders DS, Carter MJ, D'Silva J, et al. Percutaneous endoscopic gastrostomy: 
a prospective audit of the impact of guidelines in two district general hospitals 
in the United Kingdom. Am J Gastroenterol 2002;97:2239-45. 
7. Katzberg HD, Benatar M. Enteral tube feeding for amyotrophic lateral 
sclerosis/motor neuron disease. Cochrane Database Syst Rev 2011:CD004030. 
8. Dennis MS, Lewis SC, Warlow C. Effect of timing and method of enteral tube 
feeding for dysphagic stroke patients (FOOD): a multicentre randomised 
controlled trial. Lancet 2005;365:764-72. 
9. Nugent B, Lewis S, O'Sullivan JM. Enteral feeding methods for nutritional 
management in patients with head and neck cancers being treated with 
radiotherapy and/or chemotherapy. Cochrane Database Syst Rev 
2013;1:CD007904. 
10. Wanden-Berghe C, Nolasco A, Sanz-Valero J, et al. Health-related quality of 
life in patients with home nutritional support. J Hum Nutr Diet 2009;22:219-
25. 
11. Senft M, Fietkau R, Iro H, et al. The influence of supportive nutritional 
therapy via percutaneous endoscopically guided gastrostomy on the quality of 
life of cancer patients. Support Care Cancer 1993;1:272-5. 
 21 
12. Roberge C, Tran M, Massoud C, et al. Quality of life and home enteral tube 
feeding: a French prospective study in patients with head and neck or 
oesophageal cancer. Br J Cancer 2000;82:263-9. 
13. Van Bokhorst-de Van der Schuer MA, Langendoen SI, Vondeling H, et al. 
Perioperative enteral nutrition and quality of life of severely malnourished 
head and neck cancer patients: a randomized clinical trial. Clin Nutr 
2000;19:437-44. 
14. Rogers SN, Thomson R, O'Toole P, et al. Patients experience with long-term 
percutaneous endoscopic gastrostomy feeding following primary surgery for 
oral and oropharyngeal cancer. Oral Oncol 2007;43:499-507. 
15. Oates JE, Clark JR, Read J, et al. Prospective evaluation of quality of life and 
nutrition before and after treatment for nasopharyngeal carcinoma. Arch 
Otolaryngol Head Neck Surg 2007;133:533-40. 
16. Salas S, Baumstarck-Barrau K, Alfonsi M, et al. Impact of the prophylactic 
gastrostomy for unresectable squamous cell head and neck carcinomas treated 
with radio-chemotherapy on quality of life: Prospective randomized trial. 
Radiother Oncol 2009;93:503-9. 
17. El-Deiry MW, Futran ND, McDowell JA, et al. Influences and predictors of 
long-term quality of life in head and neck cancer survivors. Arch Otolaryngol 
Head Neck Surg 2009;135:380-4. 
18. Kwong JP, Stokes EJ, Posluns EC, et al. The Experiences of Patients With 
Advanced Head and Neck Cancer With a Percutaneous Endoscopic 
Gastrostomy Tube: A Qualitative Descriptive Study. Nutr Clin Pract 
2014;29:526-533. 
19. Arora G, Rockey D, Gupta S. High In-hospital mortality after percutaneous 
endoscopic gastrostomy: results of a nationwide population-based study. Clin 
Gastroenterol Hepatol 2013;11:1437-1444 e3. 
20. Stavroulakis T, Baird WO, Baxter SK, et al. The impact of gastrostomy in 
motor neurone disease: challenges and benefits from a patient and carer 
perspective. BMJ Support Palliat Care 2016;6:52-9. 
21. Zamietra K, Lehman EB, Felgoise SH, et al. Non-invasive ventilation and 
gastrostomy may not impact overall quality of life in patients with ALS. 
Amyotroph Lateral Scler 2012;13:55-8. 
 22 
22. Al-Janabi H, Nicholls J, Oyebode J. The need to "carer proof" healthcare 
decisions. BMJ 2016;352:i1651. 
23. Lingard L, Albert M, Levinson W. Grounded theory, mixed methods, and 
action research. BMJ 2008;337:a567. 
24. O'Cathain A, Murphy E, Nicholl J. Why, and how, mixed methods research is 
undertaken in health services research in England: a mixed methods study. 
BMC Health Serv Res 2007;7:85. 
25. Black N. Patient reported outcome measures could help transform healthcare. 
BMJ 2013;346:f167. 
26. Kurien M, Westaby D, Romaya C, et al. National survey evaluating service 
provision for percutaneous endoscopic gastrostomy within the UK. Scand J 
Gastroenterol 2011;46:1519-24. 
27. Leeds JS, McAlindon ME, Grant J, et al. Survival analysis after gastrostomy: 
a single-centre, observational study comparing radiological and endoscopic 
insertion. Eur J Gastroenterol Hepatol 2010;22:591-6. 
28. Cresswell J, Plano Clark VL. Designing and Conducting Mixed Methods 
Research, 2nd ed. Sage, Thousand Oaks.  2011. 
29. NICE. Guide to the methods of technology appraisal. NICE, London 2008. 
30. O'Cathain A, Murphy E, Nicholl J. Three techniques for integrating data in 
mixed methods studies. BMJ 2010;341:c4587. 
31. Brotherton A, Abbott J. Clinical decision making and the provision of 
information in PEG feeding: an exploration of patients and their carers' 
perceptions. J Hum Nutr Diet 2009;22:302-9. 
32. Carey TS, Hanson L, Garrett JM, et al. Expectations and outcomes of gastric 
feeding tubes. Am J Med 2006;119:527 e11-6. 
33. Oshima Lee E, Emanuel EJ. Shared decision making to improve care and 
reduce costs. N Engl J Med 2013;368:6-8. 
34. Stiggelbout AM, Van der Weijden T, De Wit MP, et al. Shared decision 
making: really putting patients at the centre of healthcare. BMJ 
2012;344:e256. 
35. Wilcox CM, McClave SA. To PEG or not to PEG. Clin Gastroenterol Hepatol 
2013;11:1451-2. 
 23 
36. DeLegge MH, McClave SA, DiSario JA, et al. Ethical and medicolegal 
aspects of PEG-tube placement and provision of artificial nutritional therapy. 
Gastrointest Endosc 2005;62:952-9. 
37. Walters SJ, Brazier JE. Comparison of the minimally important difference for 
two health state utility measures: EQ-5D and SF-6D. Qual Life Res 
2005;14:1523-32. 
38. Kurien M, Leeds JS, Delegge MH, et al. Mortality among patients who 
receive or defer gastrostomies. Clin Gastroenterol Hepatol 2013;11:1445-50. 
39. Bannerman E, Pendlebury J, Phillips F, et al. A cross-sectional and 
longitudinal study of health-related quality of life after percutaneous 
gastrostomy. Eur J Gastroenterol Hepatol 2000;12:1101-9. 
40. Schneider SM, Pouget I, Staccini P, et al. Quality of life in long-term home 
enteral nutrition patients. Clin Nutr 2000;19:23-8. 
41. Blomberg J, Lagergren P, Martin L, et al. Albumin and C-reactive protein 
levels predict short-term mortality after percutaneous endoscopic gastrostomy 
in a prospective cohort study. Gastrointest Endosc 2011;73:29-36. 
 
  
 24 
Table 1: Characteristics of Patients, Caregivers and the Population Controls 
  Patients Caregivers Controls 
Total Number (n) 100 100 200 
Mean Age (SD) 67 (14.7) 65 (12.2) 60 (10.1) 
Sex (M: F) 56M: 44F 46M: 54F 89M: 111F 
        
Ethnicity        
 - White 100% 99% 96% 
 - Black 0% 1% 2% 
 - Asian 0% 0% 2% 
        
Patient's Underlying Diagnosis       
 - Cerebrovascular Accident (CVA) 24% 25% - 
 - Oropharyngeal Malignancy 33% 30% - 
 - Neurodegenerative 34% 35% - 
 - Other 9% 10% - 
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Table 2: Number (Percentage) of respondents reporting no, moderate and severe 
problems in EQ-5D dimensions and mean EQ-5D index and EQ VAS scores. 
EQ-5d Domains 
Patients 
Baseline 
Patients 
(3months) 
Caregivers 
Baseline 
Caregivers  
(3 months) 
General 
Population 
Total n=100 Total n=94 Total n=100 Total n=100 Total n=200 
n (%) n (%) n (%) n (%) n (%) 
Mobility                      
No problems  40 (40.0) 37 (39.4) 86 (86.0) 86 (86.0) 192 (96.0) 
Moderate problems  53 (53.0) 50 (53.2) 13 (13.0) 13 (13.0) 8 (4.0) 
Severe problems  7 (7.0) 7 (7.4) 1 (1.0) 1 (1.0) 0 (0.0) 
Self-care                  
 
  
No problems  52 (52.0) 48 (51.1) 95 (95.0) 97 (97.0) 194 (97.0) 
Moderate problems 44 (44.0) 41 (43.6) 4 (4.0) 2 (2.0) 6 (3.0) 
Severe problems  4 (4.0) 5 (5.3) 1 (1.0) 1 (1.0) 0 (0.0) 
Usual Activities                 
 
  
No problems  35 (35.0) 36 (38.3) 92 (92.0) 93 (93.0) 195 (97.5) 
Moderate problems  60 (60.0) 53 (56.4) 7 (7.0) 6 (6.0) 4 (2.0) 
Severe problems  5 (5.0) 5 (5.3) 1 (1.0) 1 (1.0) 1 (0.5) 
Pain/ Discomfort                 
 
  
No problems  62 (62.0) 54 (57.4) 93 (93.0) 95 (95.0) 188 (94.0) 
Moderate problems  36 (36.0) 39 (41.5) 7 (7.0) 5 (5.0) 9 (4.5) 
Severe problems  2 (2.0) 1 (1.1) 0 (0.0) 0 (0.0) 3 (1.5) 
Anxiety/ Depression                 
 
  
No problems  81 (81.0) 76 (80.9) 94 (94.0) 92 (92.0) 190 (95.0) 
Moderate problems 19 (19.0) 18 (19.1) 5 (5.0) 8 (8.0) 8 (4.0) 
Severe problems  0 (0.0) 0 (0.0) 1 (1.0) 0 (0.0) 2 (1.0) 
EQ-5D index mean (±SD)   0.70 (0.27) 0.71 (0.21) 0.95 (0.15) 0.95 (0.14) 0.93 (0.14) 
EQ VAS mean (±SD)  67.2 (14.7) 67.4 (14.6) 96.5 (9.3) 96.7 (8.9) 86.2 (11.8) 
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Table 3: Mixed methods matrix exploring potential causes for HRQoL 
differences between referral indication subgroups 
Gastrostomy 
Indication 
Mean 
EQ-5D 
index 
score of 
Patients 
Defining statements made by Patients during 
Interviews  
Defining statements made by Caregivers 
during Interviews 
Cerebrovascular 
Accident 0.513 
"I've had  lots of problems with my gastrostomy, 
particularly with leakage" (B) "I don't like the look of feeding tubes" (D) 
"The feed is less pleasurable than eating" (E) "The PEG has helped him put on weight" (C) 
"The accumulation of saliva in my mouth is a big 
problem. I constantly need to spit it out" (E)   
Progressive 
Neurodegenerative 
Conditions 
0.657 
"I miss eating the things I like" (D) "I mainly look after the feeding tube and give the feeds" (B) 
"Feeding via the tube is time consuming" (E) "It took me a while to get used to the  tube but once I got the hang of it, it was ok" (B) 
"I wish I had the tube gastrostomy tube inserted 
earlier" (A) 
"The sickness is a lot better and the weight 
has come back, which is what wanted" (C) 
Oropharyngeal 
Malignancy 0.835 
"The PEG helped as I had pain at the back of my 
throat following the radiotherapy" (C) 
"I'm not concerned about the gastrostomy 
WXEHLW¶VWKHQRWNQRZLQJRIFDQFHULWVHOI
(D) 
"The support teams were really important to both 
of us" (B) 
"Without family support, the last few months 
would have been very difficult" (D) 
"I was really anxious about having the 
gastrostomy inserted" (D)   
Themes from where the defining statements were derived: 
 
(A) - Expectations of gastrostomy feeding 
 (B) - Gastrostomy management 
 (C) - Physical Wellbeing 
 (D) - Psychological and emotional welfare 
 (E)  - Social consequences of gastrostomy feeding 
 
 
